OncBioMune Receives Notice of Patent Allowance for Cancer Vaccine ProscaVax(R) in Hong Kong
April 12, 2016 11:12 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - April 12, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Pharmaceuticals Inc Signs MOU for Joint Venture With Vitel Laboratorios to Develop Novel Cancer Vaccine for Mexico and Latin America
March 29, 2016 08:30 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA --(Marketwired - March 29, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
Dr. J. Jacques Carter Joins OncBioMune Pharmaceuticals Scientific Advisory Board
March 22, 2016 10:09 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - March 22, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Receives Notice of Patent Allowance for Cancer Vaccine ProscaVax(TM) in Europe
March 16, 2016 10:56 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - March 16, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Continuing Phase 1 Trial, While Initiating Phase 2 Trial of ProscaVax for Prostate Cancer
February 23, 2016 04:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - February 23, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Invites Shareholders to Join Live Webcast Today at BIO CEO & Investors Conference
February 09, 2016 05:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - February 09, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune to Present at 18th Annual BIO CEO & Investors Conference
January 25, 2016 06:30 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - January 25, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Receives Notice of Allowance for Patent Covering New Targeted Cancer Treatments
January 22, 2016 06:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - January 22, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Adds Capital Markets Leader Daniel Hoverman to Board of Directors
January 05, 2016 11:23 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - January 05, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Selected to Present at Biotech Showcase 2016
December 16, 2015 13:27 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - December 16, 2015) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...